I am going to transfer this here as this appears to be the last thread of mine to have survived on the topic. It appears there has been a purge of lots of my old threads.
https://www.abovetopsecret.com/forum/thread1326579/pg1
Revisiting the Smokers Paradox as it is called. It is hard to get good information since "most" of the US studies counter the evidence that it exists in the first place. Early in the covid epidemic, it was noticed that "active smokers" were disproportionately under represented for contracting the disease and being hospitalized. Numerous studies in China, South Korea, France, India, and even the US confirm this (before the political US studies trying to cover this fact up).
The Japanese have been trying to find out why. They have some theories (listed below) that include ACE2 receptor protection and possibly radioactivity in tobacco could be blocking the Covid receptors themselves. Interesting information to say the least.
Has anyone else heard of any other theories and or studies / research into this?
Revisiting the Paradox of Smoking: Radioactivity in Tobacco Smoke or Suppressing the SARS-CoV-2 Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal?
https://journals.sagepub.com/doi/full/10...8221075111
The Japanese want to know why and have been / were running research:
Drugs that mimic effects of cigarette smoke reduce SARS-CoV-2's ability to enter cell
https://www.hiroshima-u.ac.jp/en/news/66516
The Paradox of the Low Prevalence of Current Smokers Among COVID-19 Patients Hospitalized in Nonintensive Care Wards: Results From an Italian Multicenter Case-Control Study
https://pubmed.ncbi.nlm.nih.gov/32964233/
The bizzare phenomenon of smokers’ paradox in the immediate outcome post acute myocardial infarction: an insight into the Malaysian National Cardiovascular Database-Acute Coronary Syndrome
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846599/
Conclusion
Smoking seems to be associated with a favourable outcome post myocardial infarction. The phenomenon of ‘smoker’s paradox’ is in fact a reality in our patients population. The definitive explanation for this unexpected protective effect of smoking remains unclear.
Could coffee offer protection from catching COVID-19?
https://phys.org/news/2022-11-coffee-covid-.html
https://www.abovetopsecret.com/forum/thread1326579/pg1
Revisiting the Smokers Paradox as it is called. It is hard to get good information since "most" of the US studies counter the evidence that it exists in the first place. Early in the covid epidemic, it was noticed that "active smokers" were disproportionately under represented for contracting the disease and being hospitalized. Numerous studies in China, South Korea, France, India, and even the US confirm this (before the political US studies trying to cover this fact up).
The Japanese have been trying to find out why. They have some theories (listed below) that include ACE2 receptor protection and possibly radioactivity in tobacco could be blocking the Covid receptors themselves. Interesting information to say the least.
Has anyone else heard of any other theories and or studies / research into this?
Revisiting the Paradox of Smoking: Radioactivity in Tobacco Smoke or Suppressing the SARS-CoV-2 Receptor, Angiotensin-Converting Enzyme 2, via Aryl-Hydrocarbon Receptor Signal?
https://journals.sagepub.com/doi/full/10...8221075111
Quote:Despite current controversies, some reports show a paradoxical mitigating effect associated with smoking in individuals with symptomatic COVID-19 compared to the general population. To explain the potential mechanisms behind the lower number of hospitalized COVID-19 patients, it has been hypothesized that cigarette smoking may reduce the odds of cytokine storm and related severe inflammatory responses through cholinergic-mediated anti-inflammatory mechanisms. Japanese scientists have recently identified a potential mechanism behind the lower numbers of COVID-19 cases amongst smokers compared to non-smokers. However, we believe that this mitigative effect may be due to the relatively high concentration of deposited energy of alpha particles emitted from naturally occurring radionuclides such as Po-210 in cigarette tobacco. Regarding COVID-19, other researchers and our team have previously addressed the anti-inflammatory and immune-modulating effects of low doses of ionizing radiation. MC-simulation using the Geant4 Monte Carlo toolkit shows that the radiation dose absorbed in a spherical cell with a radius of .9 μm for a single 5.5 MeV alpha particle is about 5.1 Gy. This energy deposition may trigger both anti-inflammatory and anti-thrombotic effects which paradoxically lower the risk of hospitalization due to COVID-19 in smokers.
The Japanese want to know why and have been / were running research:
Drugs that mimic effects of cigarette smoke reduce SARS-CoV-2's ability to enter cell
https://www.hiroshima-u.ac.jp/en/news/66516
Quote:A team of Japanese scientists demonstrates that treatment with AHR agonists decreases expression of ACE2 via AHR activation, resulting in suppression of COVID-19.
Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke to bind to a receptor in mammalian cells that inhibits production of ACE2 proteins, a process that appears to reduce the ability of the SARS-CoV-2 virus to enter the cell.
The Paradox of the Low Prevalence of Current Smokers Among COVID-19 Patients Hospitalized in Nonintensive Care Wards: Results From an Italian Multicenter Case-Control Study
https://pubmed.ncbi.nlm.nih.gov/32964233/
Quote:Results: The percentages of current smokers (4.1% vs 16%, p = .00003) and never smokers (71.6% vs 56.8%, p = .0014) were significantly different between COVID-19 and non-COVID 19 patients. COVID-19 patients had lower mean age (69.5 vs 74.2 years, p = .00085) and were more frequently males (59.2% vs 44%, p = .0011). In the logistic regression analysis, current smokers were significantly less likely to be hospitalized for COVID-19 compared with nonsmokers (odds ratio = 0.23; 95% confidence interval, 0.11-0.48, p < .001), even after adjusting for age and gender (odds ratio = 0.14; 95% confidence interval, 0.06-0.31, p < .001).
Conclusions: We reported an unexpectedly low prevalence of current smokers among COVID-19 patients hospitalized in nonintensive care wards. The meaning of these preliminary findings, which are in line with those currently emerging in literature, is unclear; they need to be confirmed by larger studies.
Implications: An unexpectedly low prevalence of current smokers among patients hospitalized for COVID-19 in some Italian nonintensive care wards is reported. This finding could be a stimulus for the generation of novel hypotheses on individual predisposition and possible strategies for reducing the risk of infection from SARS-CoV-2 and needs to be confirmed by further larger studies designed with adequate methodology.
The bizzare phenomenon of smokers’ paradox in the immediate outcome post acute myocardial infarction: an insight into the Malaysian National Cardiovascular Database-Acute Coronary Syndrome
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846599/
Conclusion
Smoking seems to be associated with a favourable outcome post myocardial infarction. The phenomenon of ‘smoker’s paradox’ is in fact a reality in our patients population. The definitive explanation for this unexpected protective effect of smoking remains unclear.
Could coffee offer protection from catching COVID-19?
https://phys.org/news/2022-11-coffee-covid-.html
And if you will confess with your mouth our Lord Yeshua, and you will believe in your heart that God has raised him from the dead, you shall have life.